Blogs

Latest Blogs

From Detection to Decision: Risk-Based Immunogenicity Testing

April 29, 2026

Immunogenicity describes treatment‑induced B‑ and T‑cell responses to therapeutics and represents a major hurdle for drug development, due to the potential impact on patient safety…

Falling drug approval rates: What should we be doing differently?

August 6, 2024

Over the years, this failure rate of drug approvals has not seen significant improvement, which begs the question - why?…

Patient Derived Organoids: Shaping the Fight Against Paediatric Brain Cancer

June 7, 2024

We highlight some of the exciting translational tools that have been developed to understand brain cancer and how these are…

World Multiple Sclerosis Day 2024: Wider access to crucial antibody therapies

May 30, 2024

World Preeclampsia Day 2024: A spotlight on the neurological consequences

May 17, 2024

Primary Immunodeficiency Week: The promise of gene therapy

April 25, 2024

In this blog, we delve deeper into the exciting world of gene therapy for PIDs.…

Primary Immunodeficiency Week: A complex landscape of genetic disorders

April 23, 2024